Search Results - "S. D. Placido"
-
1
Cancer Patients as 'Experts' in Defining Quality of Life Domains. A Multicentre Survey by the Italian Group for the Evaluation of Outcomes in Oncology (IGEO)
Published in Quality of life research (01-03-2000)“…Although the subjective nature of quality of life is generally accepted, less attention has been paid to the procedure of selecting domains to be explored with…”
Get full text
Journal Article -
2
Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up
Published in Breast cancer research and treatment (01-12-2012)“…Studies on well characterized, large populations of estrogen receptor (ER)/progesterone receptor (PgR)/HER2-negative [triple-negative (TN)] breast cancer (BC)…”
Get full text
Journal Article -
3
Circulating tumor cells in immunohistochemical subtypes of metastatic breast cancer: lack of prediction in HER2-positive disease treated with targeted therapy
Published in Annals of oncology (01-05-2012)“…Circulating tumor cells (CTCs) are associated with inferior prognosis in metastatic breast cancer (MBC). We hypothesized that the relationship between CTCs and…”
Get full text
Journal Article -
4
Fasting glucose and treatment outcome in breast and colorectal cancer patients treated with targeted agents: results from a historic cohort
Published in Annals of oncology (01-07-2012)“…We investigated pretreatment fasting glucose as a predictor of patients’ important outcomes in breast and colorectal cancers undergoing targeted therapies. In…”
Get full text
Journal Article -
5
Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer
Published in British journal of cancer (05-06-2006)“…We have evaluated the activity and safety of gefitinib, a small-molecule epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, in combination with…”
Get full text
Journal Article -
6
Topotecan Compared With No Therapy After Response to Surgery and Carboplatin/Paclitaxel in Patients With Ovarian Cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) Randomized Study
Published in Journal of clinical oncology (01-07-2004)“…Topotecan is an active second-line treatment for advanced ovarian cancer. Its efficacy as consolidation treatment after first-line standard chemotherapy is…”
Get full text
Journal Article -
7
Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma : A prospective study
Published in JNCI : Journal of the National Cancer Institute (18-06-1997)“…Tumors acquire nutrients that are essential for continued growth and an avenue for dissemination to the rest of the body by inducing angiogenesis (i.e., the…”
Get full text
Journal Article -
8
The prognostic value of lymphatic and blood vessel invasion in operable breast cancer
Published in Cancer (15-11-1995)“…This study assessed the prognostic effect of lymphatic and blood vessel invasion (LVI and BVI) on survival in a retrospective sample of 1408 patients with…”
Get more information
Journal Article -
9
Differential immunohistochemical detection of transforming growth factor α, amphiregulin and CRIPTO in human normal and malignant breast tissues
Published in International journal of cancer (03-01-1996)“…The expression of growth factors, such as transforming growth factor α (TGFα), amphiregulin (AR) and CRIPTO, a type‐1 tyrosine‐kinase growth factor…”
Get full text
Journal Article -
10
-
11
Third National Congress of Medical Oncology, 4-7 November 2001, Naples, Italy
Published in Annals of oncology (2001)Get full text
Conference Proceeding -
12
Mitomycin C plus vindesine plus etoposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP) in stage IV non-small-cell lung cancer: A phase III multicentre randomised trial
Published in Annals of oncology (01-10-1996)“…Purpose: To compare mitomycin C plus vindesine plus etoposide (MEV) vs. mitomycin C plus vindesine plus cisplatin (MVP) in the treatment of stage IV…”
Get full text
Journal Article -
13
A predictive index of axillary nodal involvement in operable breast cancer
Published in British journal of cancer (01-05-1996)“…We investigated the association between pathological characteristics of primary breast cancer and degree of axillary nodal involvement and obtained a…”
Get full text
Journal Article -
14
Prognostic significance of necrosis, elastosis, fibrosis and inflammatory cell reaction in operable breast cancer
Published in Oncology (01-07-1995)“…We analyzed retrospectively the relationships and the prognostic significance of four anatomopathological features (elastosis, fibrosis, necrosis, inflammatory…”
Get more information
Journal Article -
15
-
16
Endocrine factors in the outcome of systemic adjuvant therapy of early breast cancer
Published in Annals of the New York Academy of Sciences (30-11-1993)Get more information
Journal Article -
17
Mitomycin C and mitoxantrone in anthracycline-pretreated advanced breast cancer patients. A phase II study
Published in American journal of clinical oncology (01-06-1994)“…Twenty-one patients with anthracycline-pretreated advanced breast cancer were treated with mitomycin C plus mitoxantrone (MM), 10 mg/m2, on day 1 of a 28-day…”
Get more information
Journal Article -
18
Carboplatin, epirubicin, and VP-16 chemotherapy in the treatment of small cell lung cancer
Published in American journal of clinical oncology (01-04-1994)“…In our study, 72 SCLC patients, 23 with limited and 49 with extensive disease, were treated with carboplatin, epirubicin, and VP-16 (CEV) chemotherapy (CBDCA…”
Get more information
Journal Article -
19
Phase II study of mitomycin C, etoposide and vindesine in metastatic stage IV non-small-cell lung cancer
Published in Cancer chemotherapy and pharmacology (01-01-1991)“…A total of 72 patients with metastatic stage IV non-small-cell lung cancer (NSCLC) were treated with combination chemotherapy comprising the MEV regimen…”
Get full text
Journal Article